| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 18th, 2005 | 23 | No |
Popular Name: Zanamivir Zanamivir
Find On: PubMed — Wikipedia — Google
CAS Numbers: 139110-80-8 , [139110-80-8]
139110-80-8; C08095; Zanamivir
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
CPD000469215; SAM001246788; ZANAMIVIR HYDRATE
CPD000469215; SAM001246788; ZANAMIVIR HYDRATE; zanamivir
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -3.51 | -12.29 | -65.75 | 9 | 11 | 0 | 202 | 332.313 | 7 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Target | Antifection | Selleck Chemicals |
| Indications | antiviral | KeyOrganics Bioactives |
| Patent Database Links | EP1772155; EP1785145; EP1970061; US2005038108; US2005043399; US2005054718; US2005054719; US2007189977; US2007191322; US2007196323; US2007196325; US2007196452; US2007196453; US2007219239; US2008255073; WO2006097323; WO2007121318; WO2007128349; WO2007129290 | ChEBI |
| UniProt Database Links | GANR_BACSU; NRAM_I000F; NRAM_I00A0; NRAM_I00A1; NRAM_I01A0; NRAM_I01A1; NRAM_I01A2; NRAM_I01A3; NRAM_I02A1; NRAM_I02A2; NRAM_I02A3; NRAM_I02A4; NRAM_I02A5; NRAM_I02A6; NRAM_I02A7; NRAM_I03A0; NRAM_I03A1; NRAM_I05A1; NRAM_I06A0; NRAM_I07A0; NRAM_I18A0; NRA | ChEBI |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP00400z | NIH Clinical Collection via PubChem |
| Target | Others | Selleck Chemicals |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP00400z | NIH Clinical Collection via PubChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| NRAM-1-V | Neuraminidase (cluster #1 Of 2), Viral | Viruses | 3 | 0.52 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| NRAM_I34A1 | P03468 | Neuraminidase, I34a1 | 0.77 | 0.55 | Binding ≤ 1μM |
| NRAM_I34A1 | P03468 | Neuraminidase, I34a1 | 0.77 | 0.55 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Assembly of Viral Components at the Budding Site | |
| Budding | |
| Entry of Influenza Virion into Host Cell via Endocytosis | |
| Fusion of the Influenza Virion to the Host Cell Endosome | |
| Influenza Life Cycle | |
| Influenza Virus Induced Apoptosis | |
| Packaging of Eight RNA Segments | |
| Release | |
| Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticul | |
| Uncoating of the Influenza Virion | |
| Viral mRNA Translation |